Table 2.

Correlation of cognitive function with clinical indicators in T2DM subjects.

	MoCA score
	All groups				MCI group
	R	Pa	R	Pb	R	Pa	R	Pb
Age (years)	−0.253	<0.001			−0.208	0.020
Education levels (years)	0.427	<0.001	0.474	<0.001	0.482	<0.001	0.471	<0.001
TG (mmol/L)	−0.028	0.669	−0.011	0.876	−0.019	0.837	0.056	0.563
TC (mmol/L)	−0.043	0.523	−0.030	0.672	−0.045	0.622	0.025	0.797
LDL- c (mmol/L)	−0.044	0.513	−0.034	0.738	−0.015	0.869	−0.028	0.775
HDL- c (mmol/L)	0.078	0.241	0.143	0.043	0.203	0.026	0.301	0.001
apoA-I (g/L)	0.133	0.059	0.146	0.039	0.245	0.010	0.230	0.016
ApoB (g/L)	0.056	0.429	0.062	0.380	−0.034	0.721	−0.032	0.740

^aSpearman rank correlation analysis for abnormally distributed variables.

^bPartial correlation analysis adjusted for age.

T2DM, type 2 diabetes mellitus; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; TG, triglyceride; TC, total cholesterol; LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein cholesterol; apoA-I: apolipoprotein A1; ApoB: apolipoprotein B.